Current Research Updates for Tesamorelin-10 & Tirzepatide-30 GMP RUO
$3,900.00
Skip to product information
Current Research Updates for Tesamorelin-10 & Tirzepatide-30 GMP RUO
$3,900.00
Current Research Findings:
| Peptide | Research Summary |
|---|---|
| Tesamorelin | • Type: GHRH Analogue • Focus: Visceral (deep) abdominal fat loss. • Liver: Shown to reduce liver fat in NASH/NAFLD. • Brain: Investigated for improving cognition in older adults. • Status: FDA Approved. |
| Tirzepatide | • Type: Dual Agonist (GLP-1 + GIP). • Weight: 21% to 22.5% loss in SURMOUNT trials. • Metabolic: Superior A1C control vs. insulin. • Cardio: Positive impact on BP and lipids. • Status: FDA Approved. |
Â
Download Price Sheet for Unit Pack RUO PeptideÂ
Qty: 100 10mg/30mg
